Search for other papers by Mieke Van Hemelrijck in
Google Scholar
PubMed
Search for other papers by Thurkaa Shanmugalingam in
Google Scholar
PubMed
Search for other papers by Cecilia Bosco in
Google Scholar
PubMed
Search for other papers by Wahyu Wulaningsih in
Google Scholar
PubMed
Search for other papers by Sabine Rohrmann in
Google Scholar
PubMed
Introduction Both insulin-like growth factor 1 (IGF1) and calcium metabolisms have been linked to chronic diseases such as cardiovascular disease and cancer (1, 2, 3, 4) . IGF1 is a polypeptide hormone implicated in cell differentiation
Search for other papers by Chanyang Kim in
Google Scholar
PubMed
Search for other papers by Seungjoon Park in
Google Scholar
PubMed
mitochondrial dysfunction and oxidative stress-dependent apoptosis induced by MPP + may be promising candidates for neuroprotective agents in PD. Insulin-like growth factor (IGF)-1, a small peptide composed of 70 amino acids, is a well-known neurotrophic and
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Search for other papers by Nathalie Ly in
Google Scholar
PubMed
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Search for other papers by Sophie Dubreuil in
Google Scholar
PubMed
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Sorbonne University, Paris, France
Search for other papers by Philippe Touraine in
Google Scholar
PubMed
( 1 ). IGF-1 concentration is routinely used to assess both treatment’s efficacy and patient’s adherence when treated with GH replacement therapy (GHRT). The paramount importance of the GH–IGF axis on bone growth during childhood is well documented, as
Search for other papers by K L Gatford in
Google Scholar
PubMed
Search for other papers by G K Heinemann in
Google Scholar
PubMed
Search for other papers by S D Thompson in
Google Scholar
PubMed
Search for other papers by J V Zhang in
Google Scholar
PubMed
Search for other papers by S Buckberry in
Google Scholar
PubMed
Search for other papers by J A Owens in
Google Scholar
PubMed
Search for other papers by G A Dekker in
Google Scholar
PubMed
Search for other papers by C T Roberts in
Google Scholar
PubMed
Search for other papers by on behalf of the SCOPE Consortium in
Google Scholar
PubMed
Introduction The insulin-like growth factors (IGFs), IGF1 and IGF2, are important regulators of placental and foetal development, as well as postnatal growth and metabolism. In humans, circulating IGF1 peaks in adolescence and then falls with age
Search for other papers by P R van Dijk in
Google Scholar
PubMed
Diabetes Centre, Departments of Internal Medicine, General Practice, Langerhans Medical Research Group, Department of Internal Medicine, Division of Cell Biology, Faculty of Health Sciences, Isala Clinics, PO Box 10400, 8000 G.K. Zwolle, The Netherlands
Search for other papers by S J J Logtenberg in
Google Scholar
PubMed
Diabetes Centre, Departments of Internal Medicine, General Practice, Langerhans Medical Research Group, Department of Internal Medicine, Division of Cell Biology, Faculty of Health Sciences, Isala Clinics, PO Box 10400, 8000 G.K. Zwolle, The Netherlands
Search for other papers by K H Groenier in
Google Scholar
PubMed
Diabetes Centre, Departments of Internal Medicine, General Practice, Langerhans Medical Research Group, Department of Internal Medicine, Division of Cell Biology, Faculty of Health Sciences, Isala Clinics, PO Box 10400, 8000 G.K. Zwolle, The Netherlands
Diabetes Centre, Departments of Internal Medicine, General Practice, Langerhans Medical Research Group, Department of Internal Medicine, Division of Cell Biology, Faculty of Health Sciences, Isala Clinics, PO Box 10400, 8000 G.K. Zwolle, The Netherlands
Search for other papers by N Kleefstra in
Google Scholar
PubMed
Diabetes Centre, Departments of Internal Medicine, General Practice, Langerhans Medical Research Group, Department of Internal Medicine, Division of Cell Biology, Faculty of Health Sciences, Isala Clinics, PO Box 10400, 8000 G.K. Zwolle, The Netherlands
Diabetes Centre, Departments of Internal Medicine, General Practice, Langerhans Medical Research Group, Department of Internal Medicine, Division of Cell Biology, Faculty of Health Sciences, Isala Clinics, PO Box 10400, 8000 G.K. Zwolle, The Netherlands
Search for other papers by H J G Bilo in
Google Scholar
PubMed
Diabetes Centre, Departments of Internal Medicine, General Practice, Langerhans Medical Research Group, Department of Internal Medicine, Division of Cell Biology, Faculty of Health Sciences, Isala Clinics, PO Box 10400, 8000 G.K. Zwolle, The Netherlands
Search for other papers by H J Arnqvist in
Google Scholar
PubMed
Introduction Insulin and insulin-like growth factor 1 (IGF1) are structurally and functionally closely related peptides. IGF1, mainly synthesized in the liver after stimulation of the GH receptor, plays a central role in cell metabolism and growth
Search for other papers by A J Varewijck in
Google Scholar
PubMed
Search for other papers by A J van der Lely in
Google Scholar
PubMed
Search for other papers by S J C M M Neggers in
Google Scholar
PubMed
Search for other papers by S W J Lamberts in
Google Scholar
PubMed
Search for other papers by L J Hofland in
Google Scholar
PubMed
Search for other papers by J A M J L Janssen in
Google Scholar
PubMed
Introduction Acromegaly is characterized by excess secretion of growth hormone (GH) causing multisystem-associated morbidities and increased mortality. GH is considered as the main regulator of circulating total insulin-like growth factor 1 (IGF1
Search for other papers by R Solomon-Zemler in
Google Scholar
PubMed
Raphael Recanati Genetic Institute, Rabin Medical Center – Beilinson Hospital, Petach Tikva, Israel
Felsenstein Medical Research Center, Petach Tikva, Israel
Pediatric Genetics, Schneider Children’s Medical Center of Israel, Petach Tikva, Israel
Search for other papers by L Basel-Vanagaite in
Google Scholar
PubMed
Search for other papers by D Steier in
Google Scholar
PubMed
Search for other papers by S Yakar in
Google Scholar
PubMed
Search for other papers by E Mel in
Google Scholar
PubMed
Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, Schneider Children’s Medical Center of Israel, Petach Tikva, Israel
Search for other papers by M Phillip in
Google Scholar
PubMed
Search for other papers by L Bazak in
Google Scholar
PubMed
Search for other papers by D Bercovich in
Google Scholar
PubMed
Shalom and VardaYoran Institute for Human Genome Research, Tel Aviv University, Tel Aviv, Israel
Search for other papers by H Werner in
Google Scholar
PubMed
Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, Schneider Children’s Medical Center of Israel, Petach Tikva, Israel
Search for other papers by L de Vries in
Google Scholar
PubMed
specific (genetic or other) defect can be recognized. Growth and developmental conditions under the umbrella of congenital insulin-like growth factor-1 ( IGF-1 ) deficiencies include: (i) growth hormone (GH) releasing hormone-receptor ( GHRH-R ) defect
Search for other papers by Louise Færch in
Google Scholar
PubMed
Department of Cardiology, Department of Growth and Reproduction, Faculty of Health Sciences, Nephrology and Endocrinology H, Hillerød University Hospital, Dyrehavevej 29, DK-3400 Hillerød, Denmark
Search for other papers by Anders Juul in
Google Scholar
PubMed
Search for other papers by Ulrik Pedersen-Bjergaard in
Google Scholar
PubMed
Department of Cardiology, Department of Growth and Reproduction, Faculty of Health Sciences, Nephrology and Endocrinology H, Hillerød University Hospital, Dyrehavevej 29, DK-3400 Hillerød, Denmark
Search for other papers by Birger Thorsteinsson in
Google Scholar
PubMed
, normal GH secretion is important to avoid progression of hypoglycemic episodes into severe hypoglycemia. GH is reflected by insulin-like growth factor 1 (IGF1), which is used to evaluate the GH axis, because GH has great diurnal variation. Total IGF1 has
Search for other papers by Xu-Ting Song in
Google Scholar
PubMed
Search for other papers by Jia-Nan Zhang in
Google Scholar
PubMed
Search for other papers by Duo-Wei Zhao in
Google Scholar
PubMed
Search for other papers by Yu-Fei Zhai in
Google Scholar
PubMed
Search for other papers by Qi Lu in
Google Scholar
PubMed
Search for other papers by Mei-Yu Qi in
Google Scholar
PubMed
Search for other papers by Ming-Hai Lu in
Google Scholar
PubMed
Search for other papers by Shou-Long Deng in
Google Scholar
PubMed
Search for other papers by Hong-Bing Han in
Google Scholar
PubMed
Search for other papers by Xiu-Qin Yang in
Google Scholar
PubMed
Search for other papers by Yu-Chang Yao in
Google Scholar
PubMed
Introduction Insulin-like growth factor 1 (IGF1), also known as somatomedin C, has remarkable diversity in terms of biological effects. It is widely recognized that IGF1 is essential for the regulation of normal growth ( 1 ), development ( 2
Search for other papers by Anastasia Ibba in
Google Scholar
PubMed
Search for other papers by Francesca Corrias in
Google Scholar
PubMed
Search for other papers by Chiara Guzzetti in
Google Scholar
PubMed
Search for other papers by Letizia Casula in
Google Scholar
PubMed
Search for other papers by Mariacarolina Salerno in
Google Scholar
PubMed
Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-infantili, Università di Genova, Genova, Italy
Search for other papers by Natascia di Iorgi in
Google Scholar
PubMed
Search for other papers by Gianluca Tornese in
Google Scholar
PubMed
Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-infantili, Università di Genova, Genova, Italy
Search for other papers by Giuseppa Patti in
Google Scholar
PubMed
Search for other papers by Giorgio Radetti in
Google Scholar
PubMed
Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-infantili, Università di Genova, Genova, Italy
Search for other papers by Mohamad Maghnie in
Google Scholar
PubMed
Search for other papers by Marco Cappa in
Google Scholar
PubMed
Search for other papers by Sandro Loche in
Google Scholar
PubMed
have also shown that the best GH peak cut-off ranges from 5.1 to 6.8 μg/L, depending on the stimulation test ( 13 ). Measurement of IGF1 is also an important step in the diagnostic process ( 10 , 14 ). IGF1 is a small polypeptide hormone, whose